# Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation

> **NCT03388008** · PHASE2 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 27 (actual)

## Conditions studied

- Lung Transplant Rejection
- Antibody-mediated Rejection

## Interventions

- **DRUG:** Belatacept
- **DRUG:** Tacrolimus
- **DRUG:** ATG
- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Methylprednisolone
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT03388008
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-17
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2022-11-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03388008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03388008, "Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03388008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*